Recurrent malignant solid neoplasm Clinical Trials

Delta Trials records 71 clinical trials for Recurrent malignant solid neoplasm in its publicly accessible dataset. From the full dataset, 16 actively seeking eligible participants and 25 trials have reached completion. This research is conducted across 887 study locations around the world. An additional 30 trials are active but not currently open for enrollment. Since 2020, 4 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.